| 1 |
34779007 | Metabolic reprogramming of macrophages instigates CCL21-induced arthritis. | 2022 Feb |
1 |
| 2 |
35212163 | 2-Deoxy-d-glucose induces deglycosylation of proinflammatory cytokine receptors and strongly reduces immunological responses in mouse models of inflammation. | 2022 Apr |
1 |
| 3 |
34774071 | Metabolic reprogramming mediates hippocampal microglial M1 polarization in response to surgical trauma causing perioperative neurocognitive disorders. | 2021 Nov 13 |
1 |
| 4 |
32454039 | Glycolytic inhibitor 2-deoxyglucose suppresses inflammatory response in innate immune cells and experimental staphylococcal endophthalmitis. | 2020 Aug |
1 |
| 5 |
29552018 | Caloric Restriction Mimetic 2-Deoxyglucose Alleviated Inflammatory Lung Injury via Suppressing Nuclear Pyruvate Kinase M2-Signal Transducer and Activator of Transcription 3 Pathway. | 2018 |
1 |
| 6 |
27742831 | GM-CSF Induces Inflammatory Macrophages by Regulating Glycolysis and Lipid Metabolism. | 2016 Nov 15 |
1 |
| 7 |
24907647 | 2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro. | 2014 Oct |
1 |
| 8 |
23604542 | Isoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cells. | 2013 Jun |
1 |
| 9 |
15959754 | Activation of opioid mu-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells. | 2005 Jul |
1 |
| 10 |
10714561 | Effects of 2-deoxy-D-glucose administration on cytokine production in BDF1 mice. | 2000 Feb |
2 |